Stock ONCO ONCOPEPTIDES AB
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Oncopeptides AB

Equities

ONCO

SE0009414576

Market Closed - Nasdaq Stockholm
Other stock markets
 12:00:00 2024-07-12 pm EDT 		5-day change 1st Jan Change
2.685 SEK +5.50% Intraday chart for Oncopeptides AB +5.92% -64.95%
Jul. 02 An undisclosed buyer acquired an 9.166336% stake in Oncopeptides AB (OM:ONCO) from Industrifonden for SEK 22.4 million. CI
Jun. 27 Oncopeptides AB Selects First Candidate Drug from Its Spike Platform CI

Evolution of the average Target Price on Oncopeptides AB

Price target over the last 5 years

History of analyst recommendation changes

9287904387b56f0c6c44f40.9utnAdTJPlnsc5D0EEevD2bJ40q16MrHSk0aAOCICIg.hqhVM7GNfBrUMOXEfy_FaSGEjjn-kKzwKwZQbJO5Ye-w0gNZn4Z4PdwR9w~6a1eb76473a9ade2d6ba7f8ffe70d4a5

Analyst Recommendations on Oncopeptides AB

Oncopeptides Issues Warrants Under Loan Deal with European Investment Bank MT
Oncopeptides Announces 26% Overall Response Rate of Melflufen in Triple-Class Refractory Multiple Myeloma Patients from the Pivotal HORIZON Study CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.685 SEK
Average target price
6.1 SEK
Spread / Average Target
+127.19%
High Price Target
6.8 SEK
Spread / Highest target
+153.26%
Low Price Target
5.5 SEK
Spread / Lowest Target
+104.84%

Consensus detail

Consensus revision (last 18 months)

Ratings for Oncopeptides AB

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ONCO Stock
  4. Consensus Oncopeptides AB